DECODING THE SANOFI PASTEUR DENGUE VACCINE INFECTIVITY AND IMMUNOGENICITY USING THE HUMAN IN VITRO MIMIC® SYSTEM

被引：0
|
作者：
Luna, Ernesto [1 ]
Chehtane, Mounir [1 ]
Agrawal, Pankaj [1 ]
Mehta, Riyaz [1 ]
Byers, Anthony [1 ]
Schanen, Brian [1 ]
Guy, Bruno [2 ]
Jackson, Nicholas [2 ]
Warren, William [1 ]
Moser, Janice M. [1 ]
机构：
[1] Sanofi Pasteur, Orlando, FL USA
[2] Sanofi Pasteur, Lyon, France
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 95卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1362
引用
收藏
页码：428 / 428
页数：1
相关论文
共 50 条
  • [41] Evaluation in Mice of the Immunogenicity of a Tetravalent Subunit Vaccine Candidate Against Dengue Virus Using Mucosal and Parenteral Immunization Routes
    Lazo Vazquez, Laura
    Gil Gonzalez, Lazaro
    Marcos Lopez, Ernesto
    Perez Fuentes, Yusleidi
    Cervetto de Armas, Lazaro
    Brown Richards, Enma
    Valdes Prado, Iris
    Suzarte Portal, Edith
    Cobas Acosta, Karem
    Yaugel Novoa, Melyssa
    Romero Fernandez, Yaremis
    Guillen Nieto, Gerardo
    Hermida Cruz, Lisset
    VIRAL IMMUNOLOGY, 2017, 30 (05) : 350 - 358
  • [42] Passage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus Macaques
    Anez, German
    Men, Ruhe
    Eckels, Kenneth H.
    Lai, Ching-Juh
    JOURNAL OF VIROLOGY, 2009, 83 (20) : 10384 - 10394
  • [43] A Predictive Model of Vaccine Reactogenicity Using Data from an In Vitro Human Innate Immunity Assay System
    Pullen, Robert H.
    Sassano, Emily
    Agrawal, Pankaj
    Escobar, John
    Chehtane, Mounir
    Schanen, Brian
    Drake III, Donald R.
    Luna, Ernesto
    Brennan, Richard J.
    JOURNAL OF IMMUNOLOGY, 2024, 212 (05): : 904 - 916
  • [44] Development of human dendritic cell vaccine potency assays using TCR mimic antibodies.
    Neethling, Francisca
    Ramakrishna, Venky
    Keler, Tibor
    Weidanz, Jon
    CLINICAL IMMUNOLOGY, 2006, 119 : S46 - S47
  • [45] Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial
    Lin, Leyi
    Koren, Michael A.
    Paolino, Kristopher M.
    Eckels, Kenneth H.
    De La Barrera, Rafael
    Friberg, Heather
    Currier, Jeffrey R.
    Gromowski, Gregory D.
    Aronson, Naomi E.
    Keiser, Paul B.
    Sklar, Marvin J.
    Sondergaard, Erica L.
    Jasper, Louis E.
    Endy, Timothy P.
    Jarman, Richard G.
    Thomas, Stephen J.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (10): : 1707 - 1716
  • [46] Construction of a novel tetravalent dengue vaccine with a Salmonella Typhimurium bacterial ghost and evaluation of its immunogenicity and protective efficacy using a murine model
    Kim, Eunha
    Won, Gayeon
    Lee, John Hwa
    VACCINE, 2020, 38 (04) : 916 - 924
  • [47] IMMUNOGENICITY OF THE CYD TETRAVALENT DENGUE VACCINE (CYD-TDV) USING A COMPRESSED SCHEDULE: RANDOMIZED PHASE II STUDY IN US ADULTS
    Kirstein, Judith
    Douglas, William
    Thakur, Manoj
    Boaz, Mark
    Papa, Thomas
    Skipetrova, Anna
    Plennevaux, Eric
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 433 - 433
  • [48] Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: An alternative poxvirus vector system
    Fries, LF
    Tartaglia, J
    Taylor, J
    Kauffman, EK
    Meignier, B
    Paoletti, E
    Plotkin, S
    VACCINE, 1996, 14 (05) : 428 - 434
  • [49] In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency
    Sadaoka, Tomohiko
    Depledge, Daniel P.
    Rajbhandari, Labchan
    Venkatesan, Arun
    Breuer, Judith
    Cohen, Jeffrey I.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (17) : E2403 - E2412
  • [50] Efficacy and immunogenicity following dengue virus-1 human challenge after a tetravalent prime-boost dengue vaccine regimen: an open-label, phase 1trial
    Lyke, Kirsten E.
    Chua, Joel, V
    Koren, Michael
    Friberg, Heather
    Gromowski, Gregory D.
    Rapaka, Rekha R.
    Waickman, Adam T.
    Joshi, Sudhaunshu
    Strauss, Kathleen
    McCracken, Michael K.
    Gutierrez-Barbosa, Hernando
    Shrestha, Biraj
    Culbertson, Christopher
    Bernal, Paula
    De La Barrera, Rafael A.
    Currier, Jeffrey R.
    Jarman, Richard G.
    Edelman, Robert
    LANCET INFECTIOUS DISEASES, 2024, 24 (08): : 896 - 908
12345